CONFORMATIONAL ANOMALOUS FORMS OF TAU PROTEINS AND SPECIFIC ANTIBODIES TO THEM Russian patent published in 2007 - IPC C07K16/18 C12N5/16 C07K14/435 G01N33/577 A61K39/395 A61P25/28 

Abstract RU 2299889 C2

FIELD: immunology, biotechnology.

SUBSTANCE: invention relates to antibodies showing specificity to anomalous processed form of human tau protein that differs by conformation from the normal tau protein and doesn't bind with normal tau protein. Also, invention relates to conformational distinctive tau proteins ("tauones") and diagnostic and therapeutic aspects related to Alzheimer's disease and related taupathies. Proposed antibodies are produced by hybridomas DC-11 or Dc-11/1 deposited in ECACC at numbers 00082215 and 00082216. Also, invention described truncated forms of human tau protein that are truncated by N- and/or C-end and comprise amino acid residues from amino acid 300 to amino acid 400 in the longest isoform of human tau protein (441 amino acids residues). Above mentioned truncated forms of human tau protein can be recognized specifically by antibodies described above. Also, invention describes a method for assay of truncated forms of tau protein in a patient biological sample using a set comprising a proposed antibody and suitable container. Using the proposed invention provides a suitable target for medicinal preparations with early therapeutic effect used in Alzheimer's disease and other taupathies.

EFFECT: valuable medicinal properties of proteins.

11 cl, 15 dwg, 10 ex

Similar patents RU2299889C2

Title Year Author Number
THERAPY AND DIAGNOSTICS BASED ON PROTEINS OF TAU-MEDIATED PATHOLOGY IN ALZHEIMER DISEASE 2012
  • Novak Mikhal
  • Kontsekova Eva
  • Kovachekh Branislav
  • Zhilka Norbert
RU2645259C2
USING ANTI-TAU PS422 ANTIBODY FOR TREATING CEREBROPATHIES 2010
  • Borman Bernd
  • Gepfert Ul'Rikh
  • Grjuehninger Fiona
  • Khuber Val'Ter
  • Krell' Khans-Villi
  • Lifke Valeria
  • Mundigl' Olaf
  • Offner Zonja
  • Ozmen Lorens
  • Shreml' Mikhel'
RU2536247C2
PHARMACEUTICAL COMPOSITION 2011
  • Pfajfer, Andrea
  • Mus, Andreas
  • Van Leven, Freddi Kamil
  • Pikhlgren, Marija
  • Adolfsson, Oskar
RU2603078C2
EPITOPE, SPECIFIC TO AMYLOID BETA OLIGOMER AND ANTIBODIES 2011
  • Keshman Nejl R.
RU2644335C2
PHOSPHO-SPECIFIC ANTIBODIES RECOGNIZING TAU 2012
  • Pfajfer, Andrea
  • Mus, Andreas
  • Pikhlgren, Mariya
  • Adolfsson, Oskar
  • Van Leven, Freddi Kamil
RU2639537C2
APPLICATION OF PROTEIN YB-1 AND ITS FRAGMENTS FOR PRODUCTION OF MEDICATIONS IN TREATMENT OF ALZHEIMER'S DISEASE 2013
  • Bobkova Natal'Ja Viktorovna
  • Ovchinnikov Lev Pavlovich
  • Medvinskaja Natalija Igorevna
  • Gur'Janov Sergej Georgievich
  • Nesterova Inna Vladimirovna
  • Eliseeva Irina Aleksandrovna
  • Samokhin Aleksandr Nikolaevich
  • Aleksandrova Irina Jur'Evna
  • Nekrasov Pavel Valer'Evich
RU2561050C2
ANTI-ADDL MONOCLONAL ANTIBODY AND USE THEREOF 2011
  • Gaspar Rene S.
  • Shafrju Pol Dzh.
  • Van Fubao
  • Van Vehjzhun
  • Chzhan Ninguan'
  • Chzhao Vehj-Tsin'
  • Makkehmpbell Aleksandr
  • Sjuj Min'
RU2567808C2
THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR DEMENTIA 2013
  • Mori Khirosi
  • Tomiyama Takami
  • Matsumoto Eiti
  • Eguti Khirosi
  • Kunori Yuiti
RU2657438C2
ANTI-TAU ANTIBODIES AND METHODS OF USE 2014
  • Ejelon Gaj
  • Di Kara Deniell Mari
  • Khotsel Isidro
  • Pfajfer Andrea
  • Mus Andreas
  • Pikhlgren Mariya
  • Adolfsson Oskar
RU2661111C2
ANTISUBSTANCES AGAINST GLOBULOMER Aβ, THEIR ANTIGEN-BINDING PARTS, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, WAYS OF PRODUCTION OF MENTIONED ANTISUBSTANCES, COMPOSITIONS CONTAINING MENTIONED ANTISUBSTANCES, APPLICATION OF MENTIONED ANTISUBSTANCES AND WAYS OF APPLICATION OF MENTIONED ANTISUBSTANCES 2006
  • Bargkhorn Shtefan
  • Ehbert Ul'Rikh
  • Khillen Khajnts
  • Keller Patrik
  • Shtribinger Andreas
  • Labkovskij Boris
RU2442793C2

RU 2 299 889 C2

Authors

Novak Mikhal'

Dates

2007-05-27Published

2002-01-29Filed